UY38588A - Composición farmacéutica que comprende compuesto derivado de benzoimidazol - Google Patents
Composición farmacéutica que comprende compuesto derivado de benzoimidazolInfo
- Publication number
- UY38588A UY38588A UY0001038588A UY38588A UY38588A UY 38588 A UY38588 A UY 38588A UY 0001038588 A UY0001038588 A UY 0001038588A UY 38588 A UY38588 A UY 38588A UY 38588 A UY38588 A UY 38588A
- Authority
- UY
- Uruguay
- Prior art keywords
- pharmaceutical composition
- composition including
- derivative compound
- benzoimidazole derivative
- benzoimidazole
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
- A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
- A61K31/352—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom condensed with carbocyclic rings, e.g. methantheline
- A61K31/353—3,4-Dihydrobenzopyrans, e.g. chroman, catechin
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
- A61K31/4164—1,3-Diazoles
- A61K31/4184—1,3-Diazoles condensed with carbocyclic rings, e.g. benzimidazoles
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- Life Sciences & Earth Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Plural Heterocyclic Compounds (AREA)
Abstract
La presente invención se refiere a una composición farmacéutica para prevenir la recurrencia de la enfermedad por reflujo gastroesofágico, que comprende un derivado de benzoimidazol. La composición farmacéutica de la presente invención puede prevenir de manera eficaz la recurrencia de la enfermedad por reflujo gastroesofágico sin ningún efecto secundario durante un largo periodo de tiempo.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
KR20190018801 | 2019-02-18 |
Publications (1)
Publication Number | Publication Date |
---|---|
UY38588A true UY38588A (es) | 2020-09-30 |
Family
ID=72143624
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
UY0001038588A UY38588A (es) | 2019-02-18 | 2020-02-18 | Composición farmacéutica que comprende compuesto derivado de benzoimidazol |
Country Status (15)
Country | Link |
---|---|
US (1) | US20220125764A1 (es) |
EP (1) | EP3927340A4 (es) |
JP (2) | JP2022520276A (es) |
KR (1) | KR20200100552A (es) |
CN (1) | CN113473984A (es) |
AR (1) | AR118131A1 (es) |
AU (1) | AU2020225520A1 (es) |
BR (1) | BR112021016212A2 (es) |
CA (1) | CA3130562A1 (es) |
EA (1) | EA202192286A1 (es) |
JO (1) | JOP20210226A1 (es) |
MX (1) | MX2021009893A (es) |
SG (1) | SG11202108949PA (es) |
UY (1) | UY38588A (es) |
WO (1) | WO2020170106A1 (es) |
Families Citing this family (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA3203701A1 (en) * | 2020-12-30 | 2022-07-07 | Min Jung Kim | Pharmaceutical composition comprising tegoprazan and non-steroidal anti-inflammatory drugs |
Family Cites Families (5)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
WO2007072146A1 (en) * | 2005-12-19 | 2007-06-28 | Pfizer Japan Inc. | Chromane substituted benzimidazoles and their use as acid pump inhibitors |
EP3305291B1 (en) * | 2015-06-08 | 2021-05-19 | HK inno.N Corporation | Uses of benzimidazole derivative for nocturnal acid breakthrough |
KR101829705B1 (ko) * | 2016-09-21 | 2018-02-19 | 씨제이헬스케어 주식회사 | 안정성이 향상된 주사용 조성물 |
KR101829706B1 (ko) * | 2016-09-21 | 2018-02-19 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체의 산부가염 |
KR101960357B1 (ko) * | 2016-12-26 | 2019-03-20 | 씨제이헬스케어 주식회사 | 벤즈이미다졸 유도체를 포함하는 신규한 제제 |
-
2020
- 2020-02-17 MX MX2021009893A patent/MX2021009893A/es unknown
- 2020-02-17 CA CA3130562A patent/CA3130562A1/en active Pending
- 2020-02-17 JO JOP/2021/0226A patent/JOP20210226A1/ar unknown
- 2020-02-17 US US17/429,732 patent/US20220125764A1/en active Pending
- 2020-02-17 BR BR112021016212-7A patent/BR112021016212A2/pt unknown
- 2020-02-17 JP JP2021547865A patent/JP2022520276A/ja active Pending
- 2020-02-17 CN CN202080015631.4A patent/CN113473984A/zh active Pending
- 2020-02-17 WO PCT/IB2020/051296 patent/WO2020170106A1/en unknown
- 2020-02-17 EP EP20759153.8A patent/EP3927340A4/en active Pending
- 2020-02-17 AU AU2020225520A patent/AU2020225520A1/en active Pending
- 2020-02-17 KR KR1020200018849A patent/KR20200100552A/ko not_active Application Discontinuation
- 2020-02-17 SG SG11202108949PA patent/SG11202108949PA/en unknown
- 2020-02-17 EA EA202192286A patent/EA202192286A1/ru unknown
- 2020-02-18 UY UY0001038588A patent/UY38588A/es unknown
- 2020-02-18 AR ARP200100446A patent/AR118131A1/es unknown
-
2023
- 2023-07-07 JP JP2023111840A patent/JP2023126955A/ja active Pending
Also Published As
Publication number | Publication date |
---|---|
AU2020225520A1 (en) | 2021-10-14 |
BR112021016212A2 (pt) | 2021-10-05 |
CA3130562A1 (en) | 2020-08-27 |
EP3927340A1 (en) | 2021-12-29 |
MX2021009893A (es) | 2021-09-14 |
US20220125764A1 (en) | 2022-04-28 |
JOP20210226A1 (ar) | 2023-01-30 |
SG11202108949PA (en) | 2021-09-29 |
AR118131A1 (es) | 2021-09-22 |
CN113473984A (zh) | 2021-10-01 |
EA202192286A1 (ru) | 2021-11-18 |
KR20200100552A (ko) | 2020-08-26 |
EP3927340A4 (en) | 2022-11-02 |
JP2022520276A (ja) | 2022-03-29 |
WO2020170106A1 (en) | 2020-08-27 |
JP2023126955A (ja) | 2023-09-12 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
DOP2020000102A (es) | Compuestos útiles para inhibir a cdk7 | |
CO2020014586A2 (es) | Compuestos | |
DOP2017000178A (es) | Inhibidores selectivos de bace1 | |
ECSP11011307A (es) | Comprimidos para terapia de combinacion | |
CL2019000571A1 (es) | Formulaciones de carbamato de (r) -2-amino-3-fenilpropilo. | |
HN2011003371A (es) | Derivados de imidazolidin-2-ona 1,3-disustituida como inhibidores de cyp17 | |
CL2021002331A1 (es) | Formulaciones de anticuerpo anti-il-36r | |
CL2019003402A1 (es) | Composiciones sólidas para administración oral. | |
ECSP12012208A (es) | Formulaciones orales y sales lipofílicas de metilnaltrexona | |
CY1124413T1 (el) | Ανταγωνιστες του υποδοχεα cgrp | |
UY37153A (es) | Sulfonilamidas sustituidas para combatir parásitos animales | |
MA52019A (fr) | Schéma posologique de modulateur d'assemblage de capside | |
CL2019001628A1 (es) | Combinación farmacéutica que comprende un bloqueador del canal de calcio de tipo t. | |
DK3762009T3 (da) | Toxin-afledte indgivelseskonstrukter til oral indgivelse | |
DK3845215T3 (da) | Orale opløsninger omfattende lisdexamfetaminsalte | |
CO2021000087A2 (es) | Combinación de factor vii y de un anticuerpo biespecífico dirigido contra los factores ix y x | |
GT200900153A (es) | Agentes para combatir parasitos en animales | |
UY38588A (es) | Composición farmacéutica que comprende compuesto derivado de benzoimidazol | |
SV2019005838A (es) | Derivado de triazolopirazinona útil como un inhibidor de pde1 humana | |
EA201390603A1 (ru) | Многослойная фармацевтическая композиция, содержащая телмисартан и амлодипин | |
CL2020002128A1 (es) | Composición herbicida que comprende por lo menos un compuesto activo fenólico | |
CL2018000489A1 (es) | Formulaciones de 3-(5-amino-2-metil-4-oxo-4h-quinazolin-3-il)-piperidin-2,6-diona | |
EA200900137A1 (ru) | Комбинация ингибитора if-каналов синусного узла и бета-блокатора | |
TR201721036A2 (tr) | Flurbi̇profeni̇n modi̇fi̇ye salimli formülasyonlari | |
AR109209A1 (es) | Composición farmacéutica para prevención o tratamiento de enfermedades neurodegenerativas |